Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement (Q43552085)

24 November 2017

title

Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement (English)

1 reference

24 November 2017

Hudlicky T

1

1 reference

24 November 2017

Oppong K

2

1 reference

24 November 2017

Duan C

3

1 reference

24 November 2017

Stanton C

4

1 reference

24 November 2017

Laufersweiler MJ

5

1 reference

24 November 2017

Natchus MG

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

24 November 2017

published in

1 reference

24 November 2017

volume

11

1 reference

24 November 2017

issue

5

1 reference

24 November 2017

page(s)

627-629

1 reference

Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Design and therapeutic application of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Clinical trials of a stromelysin inhibitor. Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

Oxidative degradation of aromatic hydrocarbons by microorganisms. II. Metabolism of halogenated aromatic hydrocarbons

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900013-0

7 January 2021

10.1016/S0960-894X(01)00013-0

Identifiers

DOI

1 reference

24 November 2017

1 reference